I'm not new I've been here probably longer than you. That article just states they can meet overall production over for the next 5 years. If they have a new launch with a huge quota it could exceed compacity for some time. I'm sure they don't make all drugs at the same time. They make runs on what's needed . Meeting Vyvanse quota could have put adderall and others behind schedule and they are playing catch up.
But as you being condescending you have put more bad info on this board than just about anyone.
Market Data 
Markets 
AI
